Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18881131 | 0.98 | SOS1 (0.34) | SOS1SOS2 | |
| SCHEMBL14753705 | 0.98 | SOS1 (0.34) | SOS1SOS2 | |
| SCHEMBL21078242 | 0.92 | SOS1 (0.32) | SOS1SOS2 | |
| Formamide SCHEMBL25337234 | 0.88 | — | — | |
| SCHEMBL21371261 | 0.87 | — | — | |
| SCHEMBL12059704 | 0.83 | — | — | |
| SCHEMBL27276345 | 0.82 | SLC6A2 (0.30) | — | |
| SCHEMBL5585331 | 0.81 | — | — | |
| SCHEMBL20676286 | 0.79 | EHMT2 (0.31) | — | |
| SCHEMBL22628657 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106622359-B | A kind of SSZ-39/ZSM-5 composite molecular screen and its synthetic method and application | 中触媒新材料股份有限公司 | 2019-03-08 | — | — | CN | claimed |
| CN-106745057-B | The AEI/MFI eutectics Si-Al molecular sieve and synthetic method of a kind of binder free and application | 中触媒新材料股份有限公司 | 2018-11-13 | — | — | CN | claimed |
| CN-107531629-A | Method for preparing structure directing agent | 庄信万丰股份有限公司 | 2018-01-02 | — | — | CN | claimed |
| CN-110392607-A | Transition metal-supported zeolite, method for producing same, catalyst for nitrogen oxide purification, and method for using same | 三菱化学株式会社 | 2019-10-29 | — | — | CN | disclosed |
| CN-107074569-B | AEI-type zeolites, methods of making, and uses thereof | 三菱化学株式会社 | 2019-09-13 | — | — | CN | disclosed |
| CN-106745031-B | A kind of high silica alumina ratio SSZ-39 zeolite and its synthesis and application | 中海亚环保材料有限公司 | 2019-05-10 | — | — | CN | disclosed |
| CN-106622359-B | A kind of SSZ-39/ZSM-5 composite molecular screen and its synthetic method and application | 中触媒新材料股份有限公司 | 2019-03-08 | — | — | CN | disclosed |
| CN-106745057-B | The AEI/MFI eutectics Si-Al molecular sieve and synthetic method of a kind of binder free and application | 中触媒新材料股份有限公司 | 2018-11-13 | — | — | CN | disclosed |
| CN-107427821-A | Bimetallic Zeolite Catalyst | 庄信万丰股份有限公司 | 2017-12-01 | — | — | CN | disclosed |
| CN-107074569-A | AEI-type zeolites, methods of making, and uses thereof | 三菱化学株式会社 | 2017-08-18 | — | — | CN | disclosed |
| CN-106745057-A | The AEI/MFI eutectics Si-Al molecular sieve and synthetic method of a kind of binder free and application | 中触媒新材料股份有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106745031-A | A kind of zeolites of high silica alumina ratio SSZ 39 and its synthesis and application | 中海亚环保材料有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106622359-A | SSZ-39/ZSM-5 composite molecular sieve and synthesis method and application thereof | 中触媒新材料股份有限公司 | 2017-05-10 | — | — | CN | disclosed |
| US-20140349992-A1 | COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC. (US) | 2014-11-27 | — | — | US | disclosed |
| US-8772301-B2 | Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof | SUNOVION PHARMACEUTICALS, INC. (US) | 2014-07-08 | — | — | US | disclosed |
| EP-1836238-A1 | FUNCTIONALIZED POLYMERS AND IMPROVED TIRES THEREFROM | Bridgestone Corporation (JP) | 2007-09-26 | — | — | EP | disclosed |
| WO-2006076629-A1 | FUNCTIONALIZED POLYMERS AND IMPROVED TIRES THEREFROM | BRIDGESTONE CORPORATION (JP) | 2006-07-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140349992-A1 | COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF | GRM5, GRM2, GRM1 | SOS1 3769/4885SOS2 3826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.